X0508 4 2026-02-26 0 0001055726 INOVIO PHARMACEUTICALS, INC. INO 0001936799 Sumner Michael John 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 0 1 0 0 Chief Medical Officer 0 Common Stock 2026-02-26 4 M 0 5010 A 22860 D Common Stock 2026-02-26 4 M 0 11550 A 34410 D Common Stock 2026-02-26 4 F 0 3903 1.79 D 30507 D Restricted Stock Unit 2026-02-26 4 M 0 5010 0 D Common Stock 5010 5009 D Restricted Stock Unit 2026-02-26 4 M 0 11550 0 D Common Stock 11550 23100 D Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 34,650 restricted stock units granted on February 27, 2025 was as follows: 11,550 shares vested on February 26, 2026; 11,550 shares will vest on February 26, 2027; 11,550 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (2) herein. /s/ Michael John Sumner 2026-02-27